Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

8.42
-0.0150-0.18%
Volume:465.79K
Turnover:3.94M
Market Cap:1.53B
PE:-82.50
High:8.63
Open:8.49
Low:8.27
Close:8.43
52wk High:10.08
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.81
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-157.62
PE(LYR):2,623.95

Loading ...

Xeris Biopharma CFO Steven Pieper Disposes of 5,000 Shares Worth $42,500

Reuters
·
Yesterday

Xeris to Host XP-8121 Hypothyroidism Program Overview Webinar

Reuters
·
Aug 26

Xeris Biopharma price target raised to $12 from $9 at Barclays

TIPRANKS
·
Aug 20

Why Xeris Biopharma (XERS) Is Up 6.6% After Tighter 2026 Revenue Guidance And Wider Losses

Simply Wall St.
·
Aug 19

Mission Produce And Two Other Stocks Estimated To Be Trading Below Intrinsic Value

Simply Wall St.
·
Aug 14

Xeris Biopharma CFO Steven Pieper Sells 5,000 Shares Worth $42,500

Reuters
·
Aug 13

Xeris Biopharma Holdings, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

UPDATE: Xeris Biopharma Holdings Q2 Adj. EPS $0.00, Inline

Benzinga Earnings
·
Aug 06

Earnings Flash (XERS) Xeris Biopharma Posts Q2 Loss $0.18 a Share

MT Newswires Live
·
Aug 06

Xeris Q2 FY26 Net Loss Widens to $31.1 Million; Revenue Rises 29% to $92.1 Million

Reuters
·
Aug 06

Xeris Biopharma Holdings Q2 EPS $(0.18) Misses $0.00 Estimate, Sales $92.100M Beat $90.225M Estimate

Benzinga Earnings
·
Aug 06

Xeris Biopharma Q2 Net Income USD -31.101 Million

Reuters
·
Aug 06

Xeris Biopharma Q2 EPS USD -0.18

THOMSON REUTERS
·
Aug 06

Xeris Biopharma Outlook Full-Year 2026 Total Revenue Guidance to $385 Million to $390 Million

THOMSON REUTERS
·
Aug 06

Xeris Biopharma President, COO Kevin McCulloch Sells 15,000 Shares for $120,240

Reuters
·
Aug 05

Xeris Biopharma to Report Q2 Results, Host Conference Call

Reuters
·
Jul 23

Xeris Biopharma CFO Steven Pieper Disposes of 45,000 Common Shares Worth $385,876.20

Reuters
·
Jul 08

Xeris Names John Shannon as Chair of the Board

Reuters
·
Jul 06

Why Xeris Biopharma (XERS) Is Up 7.7% After Governance, IP, And Balance Sheet Moves - And What's Next

Simply Wall St.
·
Jul 05

Xeris Biopharma Director Nerissa Kreher Files Initial Beneficial Ownership Statement

Reuters
·
Jul 03